Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00162357 · ClinicalTrials.gov registry record · Phase 4
Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 106
- Enrollment target
NCT00162357 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 106 participants.
The verdict
NCT00162357, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.
Interventions
- DRUG Technetium Tc99m Sestamibi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2004-04 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00162357
The ClinicalTrials.gov registry entry for NCT00162357 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Technetium Tc99m Sestamibi is the first listed.
NCT00162357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00162357 about?
NCT00162357 is a clinical study titled "Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty". The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.
What is the current status of trial NCT00162357?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 106 participants. The study started on 2004-04. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00162357?
The interventions under investigation include: Technetium Tc99m Sestamibi (DRUG).
Who is sponsoring clinical trial NCT00162357?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.